VANCOUVER & MENLO PARK, Calif.--(BUSINESS WIRE)--STEMCELL Technologies, Inc. and Geron Corporation (Nasdaq:GERN) today announced that Geron has granted a license to STEMCELL Technologies (“STEMCELL”) under Geron intellectual property relating to primate pluripotent stem cells, including human embryonic stem cells.